Dr. Martin Kovach is the Director of Pharmaceutical Analytics at OnPoint. He has worked extensively with virtually every type of pharmaceutical data and is an expert in the ins-and-outs of drug approval, regulatory compliance, marketing, therapeutic uses, sales and commercial success. He is a co-author of the recent book, Empirical Challenges in Pharmaceutical Litigation and often contributes articles to OnPoint’s Pharma Corner. In addition to pharmaceuticals, Marty has focused on insurance, healthcare markets, intellectual property, antitrust and competition, and lost profits or other complex damage analyses. Marty also has deep experience in environmental and natural resource analyses, the area in which he did his Ph.D. Case work includes groundwater contamination, fisheries regulation, and air emissions. Marty has conducted independent research on international toxics policy and has co-authored articles published in the journals Agriculture and Human Values and Marine Policy. Lately, Marty has been pursuing his lifelong interest in music by learning a few of the Goldberg Variations on the piano and exercising his rusty vocal chords in the community chorus.
Favorite thing about OnPoint: Constructing arguments, solving problems.